Comparison of outcome of microneedling with autologus platelet rich plasma verses microneedling with topical insulin in the treatment of post-acne atrophic scars
Keywords:
Acne vulgaris, Micro-needling, Platelet Rich Plasma, Insulin, Post-acne atrophic scarAbstract
BACKGROUND: Treatment of acne scars involves a concoction of various treatment modalities. Minimally invasive procedures like micro-needling along with platelet rich plasma are new combination modalities used for scar remodeling with lesser downtime and side effects. The aim of this study was to compare the outcome of micro-needling with PRP versus micro-needling with topical insulin in post-acne atrophic scars, as topical insulin is natural component of body, cheap, easy to use, minimally invasive and a new therapy for post-acne scars that showed good results in the studies mentioned. No local study was found in literature research. Hence, any effect of this potentially very effective therapeutic modality needs to be investigated. OBJECTIVE: To compare the outcome of micro-needling with autologous platelet rich plasma versus micro-needling with topical insulin in the treatment of post-acne atrophic scars RESULTS: In group-A, 10(25.0%) were males and 30(75.0%) were females, while in group-B, 13(32.5%) were males and 27(67.5%) were females. The mean age of patients in group-A was 23.68±5.03 years and 24.48±4.75 years in group-B. The mean duration of scar in group-A was 4.5±2.1 years and 4.9±2.3 years in group-B. The mean exposure to sunlight in group-A was 4.9±2.3hours and 4.7±2.1hours in group-B. The mean percentage reduction in grades of scar in group-A was 55.42±12.74% and 23.33±16.79% in group-B. CONCLUSION: Micro-needling along with insulin appears to be a better therapeutic modality than micro-needling with PRP for the treatment of acne scars. This combination procedure does not require expensive equipment and could be done in all skin type patients as post-inflammatory hyperpigmentation is rarely seen after the therapy. Also this novel combination procedure is convenient for both doctors and patients as no high skills are required, no need to take I/V line and less time consuming.References
REFERENCES
Simpson NB,Cunliffe WJ.Disorders of sebaceous glands. In: Burns T, Breathnach, Cox N,Griffiths C, editors. Rook’s Text book of Dermatology. 7th ed. Blackwell science. 2004:43-75.
Goodman GJ. Post-acne scarring: a review of its pathophysiology and treatment. Dermatol Surg. 2000;26:857-871.
Jacob Cl, Dover JS, Kaminer MS. Acne scarring: a classification system and review of treatment options. J Am Acad Dermatol. 2001;45:109-117.
Lee WJ, Jung HJ, Lim HJ, Jang YH,Lee SJ, Kim DW. Serial sections of atrophic acne scarshelp in the interpretation of microscopic findings and the selection of good therapeutic modalities. J Eur Acad Dermatol Venereol. 2013;27:643-646.
Goodman GJ. Baron JA. Post acne scarring:a qualitative global scarring grading system. Dermatol Surg. 2006;32(12):1458-66.
Alster TS, Graham PM. Micro-needling: a review and practical guide. Dermatol. 2015;1(2):77-81.
Kaushik S, Hord A, Denson D, McAllister D, Smitra S, Allen M et al. Lack of pain associated with micro-fabricated micro-needles. Anesthesia and Analgesia. 2001;92(2):502-504.
Cohen BE, Elbuluk N. Micro-needling in skin of color: a review of uses and efficacy. J Am Acad Dermatol. 2016;74:348-55.
Hesseler MJ, Shyam N. Platelet-rich plasma and its utility in the treatment of acne scars: a systematic review. J Am Acad Dermatol. 2019;80:1730-45.
Zhang M, Park G, Zhou B, Luo D. Applications and efficacy of platelet- rich plasma in dermatology: a clinical review. J Cosmet Dermatol. 2018;17(5):660-5.
Marx RE. Platelet–rich plasma; evidence to support its use. J Oral Maxillo fac Surg. 2004;62(4):489-96.
Kakudo N, Kushida S, Minakata T, Suzuki K, Kusumoto K. Platelet-rich plasma promotes epithelization and angiogenesis in a split thickness skin graft donor site. Med Mol Morphol. 2011;44(4):233-6.
Kakudo N, Minakata T, Mitsui T, Kushida S, Notodihardjo FZ, Kusumoto K. Proliferation promoting effect of platelet rich plasma on human adipose derived stem cells and human dermal fibroblasts. Plast Reconstr Surg. 2008;122(5):1352-60.
Pawar M,Singh M. Micro-needling with autologous platelet rich plasma versus micro-needling with topical insulin in the treatment of post-acne atrophic scars: a simultaneous split-face comparative study. J Am Academy Dermatol. 2020.
Abbas MAM, Elgamal EEAE, Zaky MS, Elsaie ML. Micro-needling with topical vitamin C versus micro-needling with topical insulin in the treatment of atrophic post-acne scars: A split-face study. Dermatol Ther. 2022;35(5):15376.
Habbema L, Verhagen R, Van Hal R, Liu Y, Varghese B: Minimally invasive non‐thermal laser technology using laser‐induced optical breakdown for skin rejuvenation. J Biophotonics. 2012;5:194-9.
Doddaballapur S: Microneedling with dermaroller. J Cutan Aesthet Surg. 2009;2:110-111.
El-Domyati M, Medhat W: Minimally invasive facial rejuvenation: current concepts and future expectations. Expert Rev Dermatol. 2013;8:565-80.
El-Domyati M, Barakat M, Awad S, Medhat W, El-Fakahany H, Farag H. Microneedling Therapy for Atrophic Acne Scars: An Objective Evaluation. J Clin Aesthet Dermatol. 2015;8(7):36–42.
Gulanikar AD, Vidholkar R. Efficacy of platelet-rich plasma in acne scars. Clin Dermatol Rev 2019;3:109-14.
Aust MC, Reimers K, Repenning C, Stahl F, Jahn S, Guggenheim M, et al. Percutaneous collagen induction: Minimally invasive skin rejuvenation without risk of hyperpigmentation-fact or fiction. Plast Reconstr Surg. 2008;122:1553–6
.Aust MC, Fernandes D, Kolokythas P, et al. Percutaneous collagen induction therapy: an alternative treatment for scars, wrinkles and skin laxity. Plast Reconstr Surg. 2008;121:1421–29.
Fernandes D, Signorini M. Combating photoaging with percutaneous collagen induction. Clin Dermatol. 2008;26:192–99.
Porwal S, Chahar YS, Singh PK. A comparative study of combined dermaroller and platelet-rich plasma versus dermaroller alone in acne scars and assessment of quality of life before and after treatment. Indian J Dermatol 2018;63:403-8.
